Cedars Sinai Uses AlloSure in Tocilizumab Trial
BRISBANE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant …